🇺🇸 FDA
Pipeline program

INO-3112

HPV-004

Phase 2 mab completed

Quick answer

INO-3112 for Cervical Cancer is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
Cervical Cancer
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials